Project Grant R01MH139522
- The National Institute of Mental Health (NIMH) awarded a $196,120 project grant under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to adapt and refine the Critical Time Intervention (CTI) model to prevent homelessness among transitioning service members (TSMs) with mental illness. The project aims to evaluate the effectiveness of virtually delivered CTI in reducing homelessness risk for this...
- This federal Project Grant award, valued at $1,461,016.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant supports research to evaluate the effect of network-based real-time neurofeedback on mindfulness practice for reducing repetitive negative thinking in adolescents at risk for serious mental illness. The grantee, The General Hospital Corporation (dba Massachusetts General Hospital), will develop and...
- The National Institute of Mental Health (NIMH), through the Mental Health Research Grants program (CFDA 93.242), awarded a $759,581 project grant to The McLean Hospital Corporation located in Belmont, MA. The grant, titled "Harnessing Smartphones for Real-Time Detection of Affective Disturbance and Future Depression Risk in Adolescents," will fund research to develop data-driven approaches to predict and interrupt states of high negative affective states (e.g., sadness, anger, anxiety)...
- The National Institute of Mental Health (NIMH) awarded a $502,500 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Veterans Health Research Institute of Central New York, Inc. The purpose of this R34 grant is to adapt and pilot the Learning through Interactive Feedback and Training-Suicide Prevention (LIFT-UP) educational program, which aims to enhance current implementation strategies for patient-centered suicide prevention care in primary care settings. The...
- This $154,484 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support a study investigating the roles of social reward responsiveness and interpersonal stress as predictors of suicidal ideation in sexual and gender minority (SGM) youth. The study will assess these risk factors in a sample of 210 adolescents (aged 13-17) following acute psychiatric treatment for self-injurious thoughts and behaviors....
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $661,237 over 5 years to The Ohio State University to conduct research on optimizing brief coping skills interventions for suicide prevention. The study aims to intensively characterize the contexts in which patients at high risk for suicide are most likely to use and benefit from their safety planning interventions, leveraging technology and...
- This federal Project Grant award of $185,552.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to examine the neurocognitive and social factors underlying suicide risk in adolescent girls. The key objectives are to investigate two forms of sustained neurocognitive responsivity to social threat that may disrupt social connectedness and increase suicidal thoughts and behaviors in this population. The research will...
- The National Institute of Mental Health (NIMH) awarded a $196,875 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Ohio State University to conduct research on "Digital Monitoring of Emotion Regulation and Suicidal Ideation Among Individuals at Clinical High Risk for Psychosis". The 2-year study aims to examine emotion regulation as a mechanism for suicidal ideation in individuals at clinical high risk for psychosis, using ecological momentary assessment, wearable...
- The National Institute of Mental Health (NIMH) awarded a $792,441 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Mclean Hospital Corporation in Belmont, MA. The grant, awarded on April 15, 2025, will support a research project titled "Tracking the Dynamic Trajectory of Behavioral, Physiological, and Neurobiological Stress Responses in Female Adolescents at High and Low Familial Risk for Depression." The project aims to investigate how parental...
- The National Institute of Mental Health (NIMH) awarded a $206,250 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "A COPY NUMBER VARIANT DISCOVERY PIPELINE FOR INTEGRATED GENOME-EXOME SEQUENCING". The award period runs from Sep 1, 2025 to Aug 31, 2027. The project aims to develop a pipeline to detect copy number variants (CNVs) across the genome and...
The National Institute of Mental Health (NIMH) awarded a $854,029 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction." The award, effective September 1, 2025 and running through August 31, 2030, will fund the development and evaluation of a multimodal adaptive intervention to reduce suicide risk in the three months following inpatient psychiatric hospitalization. The intervention will leverage a just-in-time adaptive approach and single-session evidence-based interventions to support coping strategy use and address barriers to effective coping with suicidal thoughts. The project aims to determine the effectiveness of the multimodal adaptive intervention in reducing the risk of suicide attempts and emergency visits/re-hospitalizations for suicide risk in this high-risk population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/22/25 | ||
| Not listed | $854.0k | 8/30/25 |